Medicine in Drug Discovery

SJR Rank #3,925H-index: 28SJR: 1.145Best quartile: Q1Open AccessAPC: US$2,460Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • Drug DiscoveryQ1
  • PharmacologyQ1
  • Pharmacology (medical)Q1

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Computational Drug Discovery MethodsRNA Interference and Gene DeliveryCOVID-19 Clinical Research StudiesNanoparticle-Based Drug DeliverySARS-CoV-2 and COVID-19 ResearchAdvanced biosensing and bioanalysis techniquesCircadian rhythm and melatoninSleep and related disordersImmunotherapy and Immune ResponsesSleep and Wakefulness Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0255075100

Documents per Year

2022202509182736

Detailed Information

ISSN

2590-0986

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

8.40

References per Document

100.13

Coverage

2019-2026

Scope

Medicine in Drug Discovery is a peer-reviewed open access journal. The journal publishes original papers related to basic, preclinical and clinical studies covering all aspects of drug discovery and development. Clinical studies with a focus on efficacy and safety, target engagement, biomarkers, PK/PD, side effects etc. are also covered in the journal. Article types accepted include, but are not limited to, original research articles, reviews, case reports, short communications and editorials. The journal is in cooperation with The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences.

Metrics from SCImago Journal Rank 2025. View on SCImago